Three-dimensional radiobiological dosimetry (3D-RD) with 124I PET for 131I therapy of thyroid cancer

21 years of Biologically Effective Dose

(2010) J F Fowler   BRITISH JOURNAL OF RADIOLOGY

Pre-therapeutic 124I PET(/CT) dosimetry confirms low average absorbed doses per administered 131I activity to the salivary glands in radioiodine therapy of differentiated thyroid cancer

(2010) Walter Jentzen et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

124I PET-Based 3D-RD Dosimetry for a Pediatric Thyroid Cancer Patient: Real-Time Treatment Planning and Methodologic Comparison

(2009) R. F. Hobbs et al.   JOURNAL OF NUCLEAR MEDICINE

Calculation of the biological effective dose for piecewise defined dose-rate fits

(2009) Robert F. Hobbs et al.   MEDICAL PHYSICS

Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer

(2009) David S. Cooper et al.   THYROID

Extension of the biological effective dose to the MIRD schema and possible implications in radionuclide therapy dosimetry

(2008) Sébastien Baechler et al.   MEDICAL PHYSICS